The Potential Of Microdosing Psychedelics On Mental Health
In recent years, the scientific community has revived interest in the therapeutic use of psychedelics, especially in microdose formats, as a possible solution for various mental health disorders.. Psychedelics, which have historically been both revered in traditional rituals and stigmatized in modern society, are being reconsidered for their neuroplastic properties and their potential to catalyze profound psychological changes (Grinspoon & Bakalar, 1979).
Microdoses of psychedelics: therapeutic potential?
Microdosing involves the administration of sub-perceptual doses of psychedelic substances, such as LSD or psilocybin, meaning that the dose is low enough not to induce full psychoactive effects, but sufficient to trigger neurochemical changes in the brain. The practice has gained popularity not only among those seeking relief from mental health conditions, but also among professionals and creatives seeking to improve their cognitive performance. (Fadiman, 2011).
Psychedelics act primarily on serotonin 2A receptors in the brain, which may result in increased neuroplasticity—the brain’s ability to form new neural connections—which is believed to be crucial for therapeutic effects in the treatment of depression and other disorders. psychiatric disorders (Nichols, 2016). Additionally, recent research has suggested that microdosing may have anti-inflammatory effects, opening up another potential avenue by which these substances could alleviate symptoms of mental disorders (Family et al., 2020).
According to an international survey, A significant 79% of participants reported improvements in their mental state as a result of microdosing, citing increases in creativity, energy, and interpersonal skills, as well as a decrease in symptoms of anxiety and depression. (Polito & Stevenson, 2019). However, these studies still face the challenge of the placebo effect, requiring more rigorous and controlled research to validate these effects (Johnson et al., 2018).
Along with scientific research, it is vital to consider personal testimonies that provide an experiential perspective on microdosing psychedelics. In my personal experience, which I have documented through my YouTube channel “Psychic Reality,” I have explored the impact of a month of microdosing with psilocybin. This trip has not only changed my perception of personal well-being, but has also influenced my creativity and ability to manage daily stress.
For those interested in exploring more about how microdosing can impact real life, I invite you to watch my video series where I share in detail the changes observed and the precautions needed. You can access the specific video “One Month Taking Psilocybin Microdoses” through this link: One Month Taking Psilocybin Microdoses.
If after watching the video and reading this article you feel inspired to explore microdosing psychedelics, it is essential to proceed with caution and under the supervision of a professional. I offer personalized advice for those who wish to explore this path with confidence and knowledge. Through individualized sessions, we can design a plan that fits your specific needs and personal context, ensuring that your microdosing experience is informed and professionally supervised.
For more information on how to start this process, and for any other questions, I invite you to visit my profile in the magazine “Psicología y Mente”. There you can find more details about my approach and how I can help you navigate this exciting but complex field with confidence and expert support.
Visit my profile on “Psychology and Mind” for more information and resources. Don’t forget to subscribe to my YouTube channel, “Psychic Reality,” for more educational content and personal testimonies about microdosing and other psychology and mental health topics.
The use of microdosing, although promising, also presents significant ethical and legal dilemmas. A clear regulatory framework is essential that allows for research and, potentially, the therapeutic application of these substances, while guaranteeing the safety and well-being of patients (Sessa, 2017).
Despite the possible benefits, microdosing is not without risks. Some studies have reported side effects such as migraines and emotional dysregulation in certain individuals, highlighting the need for caution and medical supervision in its use. (Hartogsohn, 2016).
As research continues to evolve, it is crucial to maintain a balanced approach that recognizes both the therapeutic potential and risks associated with microdosing psychedelics. The future of this practice will depend on our ability to learn more about its mechanisms, effects, and safe applications in a therapeutic context.
